- Home
- TSHA vs KRO Comparison
TSHA vs KRO Comparison
Compare TSHA & KRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- KRO
- Stock Information
- Founded
- TSHA 2019
- KRO 1916
- Country
- TSHA United States
- KRO United States
- Employees
- TSHA N/A
- KRO N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- KRO Major Chemicals
- Sector
- TSHA Health Care
- KRO Industrials
- Exchange
- TSHA Nasdaq
- KRO Nasdaq
- Market Cap
- TSHA 728.4M
- KRO 598.2M
- IPO Year
- TSHA 2020
- KRO N/A
- Fundamental
- Price
- TSHA $3.02
- KRO $6.14
- Analyst Decision
- TSHA Strong Buy
- KRO Strong Sell
- Analyst Count
- TSHA 7
- KRO 2
- Target Price
- TSHA $8.71
- KRO $7.75
- AVG Volume (30 Days)
- TSHA 3.5M
- KRO 350.9K
- Earning Date
- TSHA 11-12-2025
- KRO 11-05-2025
- Dividend Yield
- TSHA N/A
- KRO 3.32%
- EPS Growth
- TSHA N/A
- KRO 3452.79
- EPS
- TSHA N/A
- KRO 0.59
- Revenue
- TSHA $8,098,000.00
- KRO $1,892,000,000.00
- Revenue This Year
- TSHA N/A
- KRO $5.77
- Revenue Next Year
- TSHA N/A
- KRO $11.07
- P/E Ratio
- TSHA N/A
- KRO $10.27
- Revenue Growth
- TSHA N/A
- KRO 6.51
- 52 Week Low
- TSHA $1.05
- KRO $4.70
- 52 Week High
- TSHA $3.40
- KRO $12.98
- Technical
- Relative Strength Index (RSI)
- TSHA 51.14
- KRO 50.24
- Support Level
- TSHA $3.16
- KRO $6.07
- Resistance Level
- TSHA $2.99
- KRO $6.39
- Average True Range (ATR)
- TSHA 0.18
- KRO 0.24
- MACD
- TSHA -0.01
- KRO -0.02
- Stochastic Oscillator
- TSHA 38.21
- KRO 38.60
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.